[Hope and disappointment in cancer medicine]

Guido Adler1, Thomas Seufferlein

  • 1Klinik für Innere Medizin I, Universitätsklinik Ulm. guido.adler@uniklinik-ulm.de

Insights

New cancer diagnostics and "magic bullet" therapies offer hope but require careful evaluation. Their success, patient compatibility, and cost-effectiveness must be rationally assessed for effective implementation in cancer care.

Area of Science:

  • Oncology
  • Pharmacology
  • Medical Diagnostics

Context:

  • Recent advancements in cancer medicine include novel diagnostic techniques and targeted therapies, often termed "magic bullets."
  • These innovations aim to improve cancer treatment efficacy and patient outcomes.

Purpose:

  • To provide a rational evaluation of new cancer diagnostic procedures and therapies.
  • To assess the success, implementation, patient preferences, and cost-benefit ratio of these innovative treatments.

Summary:

  • New cancer therapies and diagnostic tools, including "magic bullets," have emerged.
  • A critical assessment is needed to evaluate their clinical success, integration into healthcare, patient alignment, and economic viability.

Impact:

  • Informed decision-making regarding the adoption of new cancer treatments.
  • Optimizing resource allocation in oncology based on evidence of efficacy and cost-effectiveness.
  • Ensuring patient-centered care by considering individual preferences alongside therapeutic benefits.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...